MedPath
FDA Product

Bupropion Hydrochloride SR

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Bupropion Hydrochloride SR

0591-3541

Regulatory Information

0591-3541

ANDA079095

C73584

December 25, 2022

USA

These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (SR). BUPROPION HYDROCHLORIDE extended-release tablets (SR), for oral use Initial U.S. Approval: 1985

HUMAN PRESCRIPTION DRUG LABEL

51

Company Information

119723554

Active Ingredients

BUPROPION HYDROCHLORIDE

Quantity: 150 mg in 1 1

Code: ZG7E5POY8O

Class Code: ACTIB

HYDROXYPROPYL CELLULOSE (1600000 WAMW)

Code: RFW2ET671P

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

STEARIC ACID

Code: 4ELV7Z65AP

Class Code: IACT

HYDROCHLORIC ACID

Code: QTT17582CB

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

POLYETHYLENE GLYCOL, UNSPECIFIED

Code: 3WJQ0SDW1A

Class Code: IACT

Active Moieties

BUPROPION

Code: 01ZG3TPX31

© Copyright 2025. All Rights Reserved by MedPath